The pet DNA testing market is likely to strengthen its boundaries at a steady CAGR of 9.1% during the forecast period. The market is anticipated to hold a revenue of US$ 351.52 million in 2023 while it is anticipated to cross a value of US$ 839.84 million by 2033.
The research report on the pet DNA testing market states that the increase in dog owners along with the increased pet humanization is anticipated fuel the market growth. Furthermore, vendor companies are extending their research and development facilities in order to deliver better pet DNA testing modules. The spreading of genetic diseases along with the higher pet adoption is likely to garner the sales of pet DNA testing solutions.
The increased awareness around genetic health risks according to breed identification and disease-causing mutations. These tests also identify the likelihood of any disease beforehand so that the pet parents can put in efforts to prevent its effect. The tests include the monitoring of genetic activities in dogs and cats that help veterinarians decipher possible threats. The surge in dog shelters across the regions with a strong network of pet NGOs is also expected to garner market growth. The newly available dog DNA test kit along with the dog breed test solutions are penetrating the consumer base.
Pet DNA testing market analysis explains that the market is expected to flourish due to increased government initiatives. Pet parents treat their dogs and cats as an integral part of the family. Therefore, taking care of their health with regular check-ups is likely to have a positive impact on the sales of DNA testing kits. Apart from the identification of possible health risks, pet DNA tests also help end-users understand their pet’s genetics well. This allows them to give their dogs and cats the right diet and puts them under a well-planned walking regime.
Attributes | Details |
---|---|
Pet DNA Testing Market CAGR (2023 to 2033) | 9.1% |
Pet DNA Testing Market Size (2023) | US$ 351.52 million |
Pet DNA Testing Market Size (2033) | US$ 839.84 million |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The change in human behavior along with the increasing pet humanization has transformed the human-pet relationship. The rising loneliness among individuals gives birth to a new pet-human friendship. Thus, end-users take care of their pets with the same approach. From their diets to health check-ups, the increased consumer base for different pet disease diagnostic solutions is increasing. It is likely to expand more in the future with the advanced cat and dog DNA test kits coming on the market.
The market also flourishes due to the increasing curiosity of end-users in knowing the ancestral traits of the animals. Additionally, in understanding their diet regime and other specific conditions. The pet DNA tests also help in defining the stable temperament, training abilities, friendliness, versatility & athleticism of the pet. Pet DNA testing has the same scope as human genomics and genetic testing. The leading NGOs and their integration with gene technology are further anticipated to transform the pet DNA market. Government initiatives for the improvement of stray animals are pushing them to adopt pet DNA testing kits such as dog breed tests.
Key restraints for the pet DNA testing market are highly priced tests along with the unavailability of advanced technology. Furthermore, the lack of awareness among pet parents around genetic testing is limiting growth prospects. The restricted research and development activities due to the COVID-19 are limiting the demand for advanced pet DNA tests.
Increased Veterinary Budgets along with the Growing Research and Development Facilities are Garnering the Regional Growth
North America dominates the pet DNA testing market in terms of market share as it held a 42% share in 2022. The growth is attributed to the higher pet care budget, and expanded network of pet-care NGOs. Furthermore, the higher adoption of cats and dogs along with pet trends such as knowing the breed information, characteristics, and diet plan of the pet. Also, this information trends among the millennials that adopt pets. The United States being a developed nation has witnessed a high pet adoption rate post-pandemic.
China with its Higher Pet Population along with increased Pet Humanization is a Lucrative Region
China is another lucrative pet DNA testing market in the Asia Pacific region. Apart from the higher population and increased pet adoption, other factors also affect the market growth. These factors involve different approaches to DNA testing, pet humanization, and advanced testing spaces opening all around the region. Increased disposable income is also helping end users invest in pet grooming and health check-ups. The analyses of possible genetic health risks are also propelling market growth in the region.
Increased Pet Adoption, Advanced DNA Testing, and Government Initiatives are Garnering Regional Growth
The United Kingdom is another significant market as the expanding pet diagnostic industry rises in the region. Furthermore, the increase in genetic diseases and possible DNA-related healthcare threats are transforming the industry players. People treating their pets including dogs and cats as their family members are further fueling the market growth.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Category | By Test Type |
---|---|
Leading Segment | Genetic Diseases |
Market Share% (2022) / CAGR (2023 to 2033) | 35.0% |
Category | End User |
---|---|
Leading Segment | Breeders |
Market Share% (2022) / CAGR (2023 to 2033) | 8.9% (2023 to 2033) |
Based on the test type, the genetic diseases segment held the leading share of 35.0% in 2022. The growth is attributed to the surge in genetic diseases. Along with the breeder's using health & wellness tests for breed analysis, pet characteristics, and other information. Also, inheritable diseases and lower life expectancy is fueling the demand for test genetic disease testing segment.
Based on end users, the breeder segment flourishes at a CAGR of 8.9% between 2023 and 2033. The growth is attributed to the people preferring enhanced dog and cat breeds. The breeders cross-sectioning for pure breeds are likely to expand the segment’s size. These properties include colors, eye colors, height, weight, and other traits.
The key players focus on producing test kits that are affordable, easy to use, and easily available. Competitors also add new components stating more information about genetics. Companies also merge, collaborate, and acquire to expand their sales and distributional channels.
Market Developments
Technological advancement disrupts the current market trends.
The high cost of tests is likely to limit the market growth.
North America generated 42% revenue in 2022.
Altered behavior and pet humanization reshape human-pet connections.
1. Executive Summary | Pet DNA Testing Market
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022
4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Animal Type
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) Analysis By Animal Type, 2018 to 2022
5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Animal Type, 2023 to 2033
5.3.1. Dogs
5.3.2. Cats
5.4. Y-o-Y Growth Trend Analysis By Animal Type, 2018 to 2022
5.5. Absolute $ Opportunity Analysis By Animal Type, 2023 to 2033
6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Sample Type
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) Analysis By Sample Type, 2018 to 2022
6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Sample Type, 2023 to 2033
6.3.1. Blood
6.3.2. Saliva
6.3.3. Semen
6.3.4. Others
6.4. Y-o-Y Growth Trend Analysis By Sample Type, 2018 to 2022
6.5. Absolute $ Opportunity Analysis By Sample Type, 2023 to 2033
7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Test Type
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Million) Analysis By Test Type, 2018 to 2022
7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Test Type, 2023 to 2033
7.3.1. Breed Profile
7.3.2. Genetic Diseases
7.3.3. Health & Wellness
7.4. Y-o-Y Growth Trend Analysis By Test Type, 2018 to 2022
7.5. Absolute $ Opportunity Analysis By Test Type, 2023 to 2033
8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End-user
8.1. Introduction / Key Findings
8.2. Historical Market Size Value (US$ Million) Analysis By End-user, 2018 to 2022
8.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End-user, 2023 to 2033
8.3.1. Pet Owners
8.3.2. Breeders
8.3.3. Veterinarians
8.4. Y-o-Y Growth Trend Analysis By End-user, 2018 to 2022
8.5. Absolute $ Opportunity Analysis By End-user, 2023 to 2033
9. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
9.1. Introduction
9.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022
9.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033
9.3.1. North America
9.3.2. Latin America
9.3.3. Europe
9.3.4. South Asia
9.3.5. East Asia
9.3.6. Oceania
9.3.7. MEA
9.4. Market Attractiveness Analysis By Region
10. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
10.2.1. By Country
10.2.1.1. USA
10.2.1.2. Canada
10.2.2. By Animal Type
10.2.3. By Sample Type
10.2.4. By Test Type
10.2.5. By End-user
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Animal Type
10.3.3. By Sample Type
10.3.4. By Test Type
10.3.5. By End-user
10.4. Key Takeaways
11. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
11.2.1. By Country
11.2.1.1. Brazil
11.2.1.2. Mexico
11.2.1.3. Rest of Latin America
11.2.2. By Animal Type
11.2.3. By Sample Type
11.2.4. By Test Type
11.2.5. By End-user
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Animal Type
11.3.3. By Sample Type
11.3.4. By Test Type
11.3.5. By End-user
11.4. Key Takeaways
12. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
12.2.1. By Country
12.2.1.1. Germany
12.2.1.2. United kingdom
12.2.1.3. France
12.2.1.4. Spain
12.2.1.5. Italy
12.2.1.6. Rest of Europe
12.2.2. By Animal Type
12.2.3. By Sample Type
12.2.4. By Test Type
12.2.5. By End-user
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Animal Type
12.3.3. By Sample Type
12.3.4. By Test Type
12.3.5. By End-user
12.4. Key Takeaways
13. South Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
13.2.1. By Country
13.2.1.1. India
13.2.1.2. Malaysia
13.2.1.3. Singapore
13.2.1.4. Thailand
13.2.1.5. Rest of South Asia
13.2.2. By Animal Type
13.2.3. By Sample Type
13.2.4. By Test Type
13.2.5. By End-user
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Animal Type
13.3.3. By Sample Type
13.3.4. By Test Type
13.3.5. By End-user
13.4. Key Takeaways
14. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
14.2.1. By Country
14.2.1.1. China
14.2.1.2. Japan
14.2.1.3. South Korea
14.2.2. By Animal Type
14.2.3. By Sample Type
14.2.4. By Test Type
14.2.5. By End-user
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Animal Type
14.3.3. By Sample Type
14.3.4. By Test Type
14.3.5. By End-user
14.4. Key Takeaways
15. Oceania Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
15.2.1. By Country
15.2.1.1. Australia
15.2.1.2. New Zealand
15.2.2. By Animal Type
15.2.3. By Sample Type
15.2.4. By Test Type
15.2.5. By End-user
15.3. Market Attractiveness Analysis
15.3.1. By Country
15.3.2. By Animal Type
15.3.3. By Sample Type
15.3.4. By Test Type
15.3.5. By End-user
15.4. Key Takeaways
16. MEA Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
16.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
16.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
16.2.1. By Country
16.2.1.1. GCC Countries
16.2.1.2. South Africa
16.2.1.3. Israel
16.2.1.4. Rest of MEA
16.2.2. By Animal Type
16.2.3. By Sample Type
16.2.4. By Test Type
16.2.5. By End-user
16.3. Market Attractiveness Analysis
16.3.1. By Country
16.3.2. By Animal Type
16.3.3. By Sample Type
16.3.4. By Test Type
16.3.5. By End-user
16.4. Key Takeaways
17. Key Countries Market Analysis
17.1. USA
17.1.1. Pricing Analysis
17.1.2. Market Share Analysis, 2022
17.1.2.1. By Animal Type
17.1.2.2. By Sample Type
17.1.2.3. By Test Type
17.1.2.4. By End-user
17.2. Canada
17.2.1. Pricing Analysis
17.2.2. Market Share Analysis, 2022
17.2.2.1. By Animal Type
17.2.2.2. By Sample Type
17.2.2.3. By Test Type
17.2.2.4. By End-user
17.3. Brazil
17.3.1. Pricing Analysis
17.3.2. Market Share Analysis, 2022
17.3.2.1. By Animal Type
17.3.2.2. By Sample Type
17.3.2.3. By Test Type
17.3.2.4. By End-user
17.4. Mexico
17.4.1. Pricing Analysis
17.4.2. Market Share Analysis, 2022
17.4.2.1. By Animal Type
17.4.2.2. By Sample Type
17.4.2.3. By Test Type
17.4.2.4. By End-user
17.5. Germany
17.5.1. Pricing Analysis
17.5.2. Market Share Analysis, 2022
17.5.2.1. By Animal Type
17.5.2.2. By Sample Type
17.5.2.3. By Test Type
17.5.2.4. By End-user
17.6. United kingdom
17.6.1. Pricing Analysis
17.6.2. Market Share Analysis, 2022
17.6.2.1. By Animal Type
17.6.2.2. By Sample Type
17.6.2.3. By Test Type
17.6.2.4. By End-user
17.7. France
17.7.1. Pricing Analysis
17.7.2. Market Share Analysis, 2022
17.7.2.1. By Animal Type
17.7.2.2. By Sample Type
17.7.2.3. By Test Type
17.7.2.4. By End-user
17.8. Spain
17.8.1. Pricing Analysis
17.8.2. Market Share Analysis, 2022
17.8.2.1. By Animal Type
17.8.2.2. By Sample Type
17.8.2.3. By Test Type
17.8.2.4. By End-user
17.9. Italy
17.9.1. Pricing Analysis
17.9.2. Market Share Analysis, 2022
17.9.2.1. By Animal Type
17.9.2.2. By Sample Type
17.9.2.3. By Test Type
17.9.2.4. By End-user
17.10. India
17.10.1. Pricing Analysis
17.10.2. Market Share Analysis, 2022
17.10.2.1. By Animal Type
17.10.2.2. By Sample Type
17.10.2.3. By Test Type
17.10.2.4. By End-user
17.11. Malaysia
17.11.1. Pricing Analysis
17.11.2. Market Share Analysis, 2022
17.11.2.1. By Animal Type
17.11.2.2. By Sample Type
17.11.2.3. By Test Type
17.11.2.4. By End-user
17.12. Singapore
17.12.1. Pricing Analysis
17.12.2. Market Share Analysis, 2022
17.12.2.1. By Animal Type
17.12.2.2. By Sample Type
17.12.2.3. By Test Type
17.12.2.4. By End-user
17.13. Thailand
17.13.1. Pricing Analysis
17.13.2. Market Share Analysis, 2022
17.13.2.1. By Animal Type
17.13.2.2. By Sample Type
17.13.2.3. By Test Type
17.13.2.4. By End-user
17.14. China
17.14.1. Pricing Analysis
17.14.2. Market Share Analysis, 2022
17.14.2.1. By Animal Type
17.14.2.2. By Sample Type
17.14.2.3. By Test Type
17.14.2.4. By End-user
17.15. Japan
17.15.1. Pricing Analysis
17.15.2. Market Share Analysis, 2022
17.15.2.1. By Animal Type
17.15.2.2. By Sample Type
17.15.2.3. By Test Type
17.15.2.4. By End-user
17.16. South Korea
17.16.1. Pricing Analysis
17.16.2. Market Share Analysis, 2022
17.16.2.1. By Animal Type
17.16.2.2. By Sample Type
17.16.2.3. By Test Type
17.16.2.4. By End-user
17.17. Australia
17.17.1. Pricing Analysis
17.17.2. Market Share Analysis, 2022
17.17.2.1. By Animal Type
17.17.2.2. By Sample Type
17.17.2.3. By Test Type
17.17.2.4. By End-user
17.18. New Zealand
17.18.1. Pricing Analysis
17.18.2. Market Share Analysis, 2022
17.18.2.1. By Animal Type
17.18.2.2. By Sample Type
17.18.2.3. By Test Type
17.18.2.4. By End-user
17.19. GCC Countries
17.19.1. Pricing Analysis
17.19.2. Market Share Analysis, 2022
17.19.2.1. By Animal Type
17.19.2.2. By Sample Type
17.19.2.3. By Test Type
17.19.2.4. By End-user
17.20. South Africa
17.20.1. Pricing Analysis
17.20.2. Market Share Analysis, 2022
17.20.2.1. By Animal Type
17.20.2.2. By Sample Type
17.20.2.3. By Test Type
17.20.2.4. By End-user
17.21. Israel
17.21.1. Pricing Analysis
17.21.2. Market Share Analysis, 2022
17.21.2.1. By Animal Type
17.21.2.2. By Sample Type
17.21.2.3. By Test Type
17.21.2.4. By End-user
18. Market Structure Analysis
18.1. Competition Dashboard
18.2. Competition Benchmarking
18.3. Market Share Analysis of Top Players
18.3.1. By Regional
18.3.2. By Animal Type
18.3.3. By Sample Type
18.3.4. By Test Type
18.3.5. By End-user
19. Competition Analysis
19.1. Competition Deep Dive
19.1.1. Wisdom Panel
19.1.1.1. Overview
19.1.1.2. Product Portfolio
19.1.1.3. Profitability by Market Segments
19.1.1.4. Sales Footprint
19.1.1.5. Strategy Overview
19.1.1.5.1. Marketing Strategy
19.1.2. Orivet Genetic Pet Care Ltd.
19.1.2.1. Overview
19.1.2.2. Product Portfolio
19.1.2.3. Profitability by Market Segments
19.1.2.4. Sales Footprint
19.1.2.5. Strategy Overview
19.1.2.5.1. Marketing Strategy
19.1.3. Embark Veterinary, Inc.
19.1.3.1. Overview
19.1.3.2. Product Portfolio
19.1.3.3. Profitability by Market Segments
19.1.3.4. Sales Footprint
19.1.3.5. Strategy Overview
19.1.3.5.1. Marketing Strategy
19.1.4. Dognomics
19.1.4.1. Overview
19.1.4.2. Product Portfolio
19.1.4.3. Profitability by Market Segments
19.1.4.4. Sales Footprint
19.1.4.5. Strategy Overview
19.1.4.5.1. Marketing Strategy
19.1.5. DNA MY DOG
19.1.5.1. Overview
19.1.5.2. Product Portfolio
19.1.5.3. Profitability by Market Segments
19.1.5.4. Sales Footprint
19.1.5.5. Strategy Overview
19.1.5.5.1. Marketing Strategy
19.1.6. Basepaws, Inc.
19.1.6.1. Overview
19.1.6.2. Product Portfolio
19.1.6.3. Profitability by Market Segments
19.1.6.4. Sales Footprint
19.1.6.5. Strategy Overview
19.1.6.5.1. Marketing Strategy
19.1.7. Neogen Corp.
19.1.7.1. Overview
19.1.7.2. Product Portfolio
19.1.7.3. Profitability by Market Segments
19.1.7.4. Sales Footprint
19.1.7.5. Strategy Overview
19.1.7.5.1. Marketing Strategy
19.1.8. GenSolDiagnostics, LLC
19.1.8.1. Overview
19.1.8.2. Product Portfolio
19.1.8.3. Profitability by Market Segments
19.1.8.4. Sales Footprint
19.1.8.5. Strategy Overview
19.1.8.5.1. Marketing Strategy
19.1.9. FidoCure
19.1.9.1. Overview
19.1.9.2. Product Portfolio
19.1.9.3. Profitability by Market Segments
19.1.9.4. Sales Footprint
19.1.9.5. Strategy Overview
19.1.9.5.1. Marketing Strategy
19.1.10. PetDx
19.1.10.1. Overview
19.1.10.2. Product Portfolio
19.1.10.3. Profitability by Market Segments
19.1.10.4. Sales Footprint
19.1.10.5. Strategy Overview
19.1.10.5.1. Marketing Strategy
20. Assumptions & Acronyms Used
21. Research Methodology
Explore Healthcare Insights
View Reports